Difference between revisions of "Poorly differentiated carcinoma of the lung"

From Libre Pathology
Jump to navigation Jump to search
(split out)
 
Line 1: Line 1:
'''Poorly differentiated carcinoma of the lung''', also '''poorly differentiated lung carcinoma''', is an unclassified [[lung tumour]] with features of [[small cell carcinoma of the lung|small cell carcinoma]] and [[non-small cell carcinoma]].   
'''Poorly differentiated carcinoma of the lung''', also '''poorly differentiated lung carcinoma''', is an unclassified [[lung tumour]] with features of [[small cell carcinoma of the lung|small cell carcinoma]] and [[non-small cell lung carcinoma]].   


Categorically, it is group of [[non-small cell lung cancer]].
Categorically, it is grouped with [[non-small cell lung cancer]].


==General==
==General==
Line 28: Line 28:
The tumour stains as follows:  
The tumour stains as follows:  
POSITIVE: EMA, AE1/AE3.  
POSITIVE: EMA, AE1/AE3.  
NEGATIVE: TTF-1, chromogranin A, synaptophysin, CD56, CD45.
NEGATIVE: TTF-1, chromogranin A, synaptophysin, CD56, CD45, CK5/6, p63.


The morphology would be compatible with small cell carcinoma or basaloid  
The morphology would be compatible with small cell carcinoma or basaloid  
Line 39: Line 39:
==See also==
==See also==
*[[Lung tumours]].
*[[Lung tumours]].
*[[Non-small cell lung carcinoma]].


[[Category:Lung tumours]]
[[Category:Lung tumours]]

Revision as of 03:51, 18 November 2015

Poorly differentiated carcinoma of the lung, also poorly differentiated lung carcinoma, is an unclassified lung tumour with features of small cell carcinoma and non-small cell lung carcinoma.

Categorically, it is grouped with non-small cell lung cancer.

General

  • Should be used when the DDx is small cell carcinoma versus non-small cell carcinoma.
  • Poorly differentiated carcinoma leaves the surgical options on the table.

Microscopic

Features:

  • Small cell carcinoma/basaloid squamous cell carcinoma-like tumour.

DDx:

IHC

Sign out

Lung, Left Lower Lobe, Core Biopsy: 
- POORLY DIFFERENTIATED CARCINOMA, see comment. 

COMMENT: 
The tumour stains as follows: 
POSITIVE: EMA, AE1/AE3. 
NEGATIVE: TTF-1, chromogranin A, synaptophysin, CD56, CD45, CK5/6, p63.

The morphology would be compatible with small cell carcinoma or basaloid 
squamous cell carcinoma.  

The neuroendocrine markers (chromogranin A, synaptophysin, CD56) and the squamoid 
markers available (p63, CK5/6) are negative; thus, the tumour is not further classified. 

See also